公开(公告)号：US09808439B2

公开(公告)日：2017-11-07

申请号：US14848360

申请日：2015-09-09

Applicant: Macau University of Science and Technology

Inventor： Wen-zhe Ma ,  Sen-ling Feng ,  Xiao-jun Yao ,  Zhong-wen Yuan ,  Liang Liu ,  Ying Xie

IPC: A61K31/352 ,  A61K31/337 ,  A61K45/06 ,  A61K31/704

CPC classification number: A61K31/352 ,  A61K31/337 ,  A61K31/704 ,  A61K45/06 ,  A61K2300/00

Abstract: The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is tangeretin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.

公开(公告)号：US09808477B2

公开(公告)日：2017-11-07

申请号：US14848358

申请日：2015-09-09

Applicant: Macau University of Science and Technology

Inventor： Wen-zhe Ma ,  Sen-ling Feng ,  Xiao-jun Yao ,  Zhong-wen Yuan ,  Liang Liu ,  Ying Xie

IPC: A61K31/352 ,  A61K31/337 ,  A61K45/06 ,  A61K31/704

CPC classification number: A61K31/366 ,  A61K31/337 ,  A61K31/352 ,  A61K31/704 ,  A61K45/06 ,  A61K2300/00

Abstract: The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is nobiletin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.